Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Age-related macular degeneration (AMD ... This may be a way to stop vision loss from GA without brand-new treatments. Geographic atrophy is a complex disease, and there’s still a lot we don ...

Study from Case Western Reserve University and VA Northeast Ohio Healthcare System examines genetic risk profiles across ...

In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

The RCT TALON, which compares brolucizumab and aflibercept for the treatment of neovascular (wet) age-related macular degeneration, shows that there is another way. In the TALON study, a treat-and ...

Gemvax & Kael Co. Ltd. has identified peptides reported to be useful for the treatment of age-related macular degeneration (AMD), cerebral amyloid angiopathy and Alzheimer’s disease.

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments ...